NFE2L2 and lung cancer: KEAP1 is frequently mutated in lung cancer, and KEAP1-mutant lung cancer exhibits NRF2 hyperactivation and aberrant expression of SLC7A11 (Cancer Genome Atlas Research, 2012, 2014).